PULMOCLEAR Inhalation Solution restores sufficient moisture to the mucous membranes of your respiratory passages, preventing the discomfort of them drying out. This supports the natural cleaning process of the respiratory tract, a noticeably positive contribution in cases of inflammation as well as in cases of increased exposure to dust and air pollution (e.g. caused by dust or tobacco smoke). The medications need to be administered orally post-meal. Do not overuse or eliminate the intake of medication immediately as it can cause several side effects and withdrawal symptoms. Consult your medical professional for the right dosage as per your age, gender and severity of the case. Bronchiectasis: British Thoracic Society Guidelines for the treatment of non-CF bronchiectasis suggest that hypertonic sodium chloridemay be considered for use prior to airway clearance to increasesputum yield, reduce sputum viscosity and improve ease of expectoration (BTS July 2010). For existing patients already receiving supplies from primary care. Repatriation of these patients is not expected.

Patient must avoid consuming alcohol while taking Pulmoclear Tablet. It is unsafe to take both simultaneously. Kindly consult your doctor before taking it. Introducing Pulmoclear Inhalation Solution – Saline Inhalation Solution, a reliable and effective solution for respiratory care. Pulmoclear is available in two variants, Pulmoclear Hypertonic Sodium Chloride Solution and Pulmoclear Isotonic Sodium Chloride Solution, catering to different respiratory needs. Ambroxol theophyllinacetate- Drug Information Portal [Internet]. druginfo.nlm.nih.gov. 2019 [Cited 09 May 2019]. Available from: Pulmoclear tablet contains a combination of acebrophylline and acetylcysteine as active ingredients. Acebrophylline belongs to the class of bronchodilators, which works by relaxing the airways and making breathing easier. Acetylcysteine is a mucolytic that helps to loosen the cough, thus making the expulsion of the cough easy. Bronchiectasis: British Thoracic Society Guidelines for the treatmentof non-CF bronchiectasis suggest that hypertonic sodium chloridemay be considered for use prior to airway clearance to increasesputum yield, reduce sputum viscosity and improve ease of expectoration (BTS July 2010).Approved in accordance with Clinical Commissioning Urgent Policy Statement: Cystic Fibrosis Modulator Therapies (NHS England URN: 200810P, replaces 200410P) Common side effects of the disease may include vomiting, nausea, abdominal pain, drowsiness, gastrointestinal discomfort and heartburn. Other symptoms that are rare in occurrence are shortness of breath, loss of appetite, esophageal obstruction, airway inflammation, increased white blood cell count, urticaria, rashes, itching, constipation and diarrhoea. No new patients to receive prescriptions in primary care. Patients already receiving Red Medicines in primary care should be handled on a case by case basis with the support of the Medicines Optimisation team.

Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC. Nottingham and Nottinghamshire ICB, Greener Inhaler Alternatives Medicines Optimisation Toolkit for ADULTS In concentrations of 3-14%, hypertonic saline has been shown toimprove tracheobronchial clearance in patients with chronicbronchitis, CF, asthma and normal individuals. Pulmoclear Tablet does not affect the patients consciousness, thus driving efficiency is not hindered. NHS England: Clinical Commissioning Urgent Policy Statement ivacaftor for cystic fibrosis: “off-label” use in patients with named rarer mutationsAns : Pulmoclear is a xanthine derivative. It contains Acebrophylline and AcetylCysteine as active ingredients. Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice and has a working experience and knowledge within a speciality area

The time taken for this medicine to show its effect is subject to vary based on the intended use and form of medicine consumed. Pulmoclear Tablet is probably safe to be used in patient with kidney disease. Available data suggests that adjustment of dose is not required. Kindly consult your doctor before taking it. NHS England: Clinical Commissioning Urgent Policy Statement tezacaftor/ivacaftor for cystic fibrosis: “off-label” use in patients with named rarer mutationsThe time duration for which this medicine remains effective in the body is subject to variations based on the form of medicine consumed. Sucrose, Skimmed Milk powder, Oleic Sunflower oil powder, Whole milk powder, Vegetable fat powder, Sodium Caseinate, Whey protein concentrate, FOS, Soy Protein Isolate, Maltodextrin, L-Glutamine, Minerals, L-Arginine, Strawberry flavour, Beetroot juice powder, Vitamins, Choline, N-acetylcysteine.